The Appalachian Node of the National Institute on Drug Abuse Clinical Trials Network (NIDA-CTN) is a collaboration between University of Pittsburgh, West Virginia University, and Penn State University.
The NIDA-CTN Appalachian Node is co-directed by Drs. Jane Liebschutz (University of Pittsburgh) and Erin Winstanley (West Virginia University), with a team of accomplished clinical and research collaborators. We organize and participate in national, community-based multi-site trials and subsequently disseminate research findings to physicians, clinicians, providers, and patients.
The Appalachian Node enables medical and specialty treatment providers, treatment researchers, participating patients, and NIDA to “cooperatively develop, validate, refine, and deliver new treatment options to patients.”
The NIDA-CTN Appalachian Node is co-directed by Drs. Erin Winstanley (West Virginia University) and Jane Liebschutz (University of Pittsburgh), with a team of accomplished clinical and research collaborators.
The Appalachian Node maintains a diverse portfolio of projects and activities to further the mission of NIDA-CTN.
